Adenoma detection and subsequent colorectal cancer risk: is the race really over?

A high adenoma detection rate (ADR) is vital for effective colorectal cancer (CRC) screening, but evidence suggests limited additional benefit beyond a certain threshold. In a pooled analysis of five large colonoscopy studies, we confirmed an inverse relationship between ADR and postcolonoscopy CRC risk. In primary screening, an ADR of at least 27% is essential. While higher ADRs further reduce risk, the benefit plateaus beyond 34%, offering minimal added value. Efforts should focus on supporting low-performing endoscopists to meet quality standards. ADR benchmarks in faecal immunochemical test (FIT)-based programmes warrant further investigation.

Authors

Institutions

Publication Details

Journal
Gut
Published
2025-06-27
DOI
https://doi.org/10.1136/gutjnl-2025-335225
Citations
2
Primary Topic
Colorectal Cancer Screening and Detection
Type
article
Field-Weighted Citation Impact
2.09
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adenoma detection and subsequent colorectal cancer risk: is the race really over?

Marco Di Marco, Antonio Facciorusso, Cesare Hassan, Cristiano Spada et al.
2 citations
Gut
Colorectal Cancer Screening and Detection
2.09
article

Adenoma detection and subsequent colorectal cancer risk: is the race really over?

Marco Di Marco, Antonio Facciorusso, Cesare Hassan, Cristiano Spada, Mário Jorge Dinis-Ribeiro, Nastazja Pilonis, Leonardo Frazzoni, Pieter H.A. Wisse, Manon C.W. Spaander, Angelo De Padova, Giovanni Barbara, Giulio Antonelli, Evelien Dekker, Michael Bretthauer, Lorenzo Fuccio, F. Orlandini, Michał F. Kamiński
article en
2 citations

Abstract

A high adenoma detection rate (ADR) is vital for effective colorectal cancer (CRC) screening, but evidence suggests limited additional benefit beyond a certain threshold. In a pooled analysis of five large colonoscopy studies, we confirmed an inverse relationship between ADR and postcolonoscopy CRC risk. In primary screening, an ADR of at least 27% is essential. While higher ADRs further reduce risk, the benefit plateaus beyond 34%, offering minimal added value. Efforts should focus on supporting low-performing endoscopists to meet quality standards. ADR benchmarks in faecal immunochemical test (FIT)-based programmes warrant further investigation.

Gut
Università Cattolica del Sacro Cuore (IT), Oslo University Hospital (NO), Humanitas University (IT), University of Salento (IT), University of Oslo (NO), Erasmus MC (NL), Agostino Gemelli University Polyclinic (IT), Viking Development Group (Norway) (NO), IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT), Città di Castello Hospital (IT), IPO Porto (PT), Ospedale Infermi di Rimini (IT), Postgraduate School of Molecular Medicine (PL), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), Amsterdam University Medical Centers (NL), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University of Amsterdam (NL), University of Bologna (IT)
Good health and well-being
Openalex Percentile: Top 12%
Colorectal Cancer Screening and Detection
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.